RAW Rolling Papers acquires RAW Genetics IP for cannabis expansion

RAW’s parent company, HBI Innovations, has acquired ownership of the RAW Genetics brand IP in an assignment and license-back deal that keeps the genetics business operating through 2026. The move sets up new genetics, seed and collaboration plans under HBI starting in 2027.

Why it matters: - The deal gives HBI Innovations a direct path into cannabis genetics and seeds, expanding RAW beyond rolling papers and accessories. - The acquisition could deepen RAW’s role in cannabis culture by connecting its paper brand with breeders, growers and future product development. - RAW Genetics’ transition raises the possibility of new branded genetics, seed offerings and collaborations under HBI stewardship in 2027.

What happened: - Josh Kesselman, founder of RAW Rolling Papers and publisher of High Times Magazine, announced that HBI Innovations bought the RAW Genetics brand name marks. - HBI Innovations and RAW Genetics entered an assignment and license-back agreement. - The agreement transfers ownership of the RAW Genetics intellectual property to HBI. - RAW Genetics will keep operating through the end of 2026 during a limited transition period. - New launches under HBI Innovations are planned for 2027. - The parties said the deal was reached amicably and that both sides will continue collaborating during the transition.

The details: - RAW Genetics was founded by legacy breeder Bradley Van Gundy and his brother Mason Yerger. - The brand is known for cultivars including Stuffed French Toast, Z Pie, Zlushiez, Kami Kush and the Zikigai line. - RAW Genetics also built demand with flavor-forward profiles, strong bag appeal and awards nationwide. - Van Gundy has already begun work on a new project called Zikigai Garden. - Van Gundy said the agreement creates a path forward that preserves the spirit of both brands while opening new growth opportunities. - Kesselman said RAW Genetics adds to RAW’s culture-driven approach and creates room for genetics, seeds and future collaborations. - RAW said additional details on future genetics, seed offerings and collaborations will be announced later.

Between the lines: - The acquisition suggests RAW is using brand equity from smoking accessories to move further upstream into the cannabis supply chain. - The license-back structure gives RAW Genetics continuity while HBI takes control of the IP, reducing disruption during the handoff. - The timing leaves room for HBI to build a genetics strategy before public launches begin in 2027.

What's next: - RAW Genetics will continue operating through the end of 2026 under the transition agreement. - HBI Innovations is expected to unveil new genetics and seed initiatives in 2027. - More information on collaborations and product plans will come later.

The bottom line: - RAW is turning a cultural brand into a broader cannabis platform, and RAW Genetics is the first major step in that expansion.